Insights

Loading spinner
Gathering insights about Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting

Similar companies to Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting

Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting Tech Stack

Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting uses 8 technology products and services including Varnish, WordPress, MySQL, and more. Explore Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's tech stack below.

  • Varnish
    Caching
  • WordPress
    Content Management System
  • MySQL
    Database
  • Modernizr
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • OpenResty
    Web Servers
  • Nginx
    Web Servers

Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's Email Address Formats

Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting uses at least 1 format(s):
Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting Email FormatsExamplePercentage
First.Last@somahlution.comJohn.Doe@somahlution.com
38%
FirstL@somahlution.comJohnD@somahlution.com
17%
First@somahlution.comJohn@somahlution.com
7%
First.Last@somahlution.comJohn.Doe@somahlution.com
38%

Frequently Asked Questions

Where is Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's headquarters located?

Minus sign iconPlus sign icon
Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's main headquarters is located at 225 Chimney Corner Lane, Suite 2001. The company has employees across 1 continents, including North America.

What is Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's phone number?

Minus sign iconPlus sign icon
You can contact Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's official website and social media links?

Minus sign iconPlus sign icon
Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's official website is somahlution.com and has social profiles on LinkedIn.

What is Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's SIC code NAICS code?

Minus sign iconPlus sign icon
Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting have currently?

Minus sign iconPlus sign icon
As of December 2025, Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting has approximately 20 employees across 1 continents, including North America. Key team members include Vice President - Regulatory Affairs And Quality: J. C.Sr.Director, Product Development: B. C.Sr.Director, Product Development: B. C.. Explore Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's employee directory with LeadIQ.

What industry does Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting belong to?

Minus sign iconPlus sign icon
Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting operates in the Biotechnology Research industry.

What technology does Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting use?

Minus sign iconPlus sign icon
Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's tech stack includes VarnishWordPressMySQLModernizrjQueryPHPOpenRestyNginx.

What is Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's email format?

Minus sign iconPlus sign icon
Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's email format typically follows the pattern of First.Last@somahlution.com. Find more Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting email formats with LeadIQ.

When was Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting founded?

Minus sign iconPlus sign icon
Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting was founded in 2010.

Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting

Biotechnology ResearchFlorida, United States11-50 Employees

The DuraGraft® Difference: DuraGraft is a vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure. 

Not Available In The United States.

Section iconCompany Overview

Headquarters
225 Chimney Corner Lane, Suite 2001
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
11-50

Section iconFunding & Financials

  • $10M$25M

    Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Somahlution: DuraGraft Vascular Graft Treatment Improves Outcomes in Coronary Artery Bypass Grafting's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.